Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: W9E3353E8J

Structure

InChI Key LQVXSNNAFNGRAH-QHCPKHFHSA-N
Smile C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1
InChI
InChI=1S/C23H24FN9O/c1-23(21(34)26-15-7-8-18(24)25-13-15)9-3-10-32(23)22-28-20(17-4-2-11-33(17)31-22)27-19-12-16(29-30-19)14-5-6-14/h2,4,7-8,11-14H,3,5-6,9-10H2,1H3,(H,26,34)(H2,27,28,29,30,31)/t23-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C23H24FN9O
Molecular Weight 461.51
AlogP 3.61
Hydrogen Bond Acceptor 8.0
Hydrogen Bond Donor 3.0
Number of Rotational Bond 6.0
Polar Surface Area 116.13
Molecular species NEUTRAL
Aromatic Rings 4.0
Heavy Atoms 34.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Insulin-like growth factor I receptor inhibitor PubMed PubMed
Primary Target
Insulin-like growth factor I receptor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Breast Neoplasms 2 D001943 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
CAS NUMBER 1001350-96-4
ChEBI 88339
ChEMBL CHEMBL575448
DrugBank DB15399
FDA SRS W9E3353E8J
Guide to Pharmacology 7952
PDB EBI
PubChem 24785538
SureChEMBL SCHEMBL1810808
ZINC ZINC000043203317